Kevin Fischbeck
Stock Analyst at B of A Securities
(2.16)
# 2,874
Out of 4,967 analysts
174
Total ratings
60.98%
Success rate
1.32%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Neutral | $290 → $325 | $310.29 | +4.74% | 25 | Aug 18, 2025 | |
| ARDT Ardent Health | Downgrades: Underperform | $16 → $15 | $12.74 | +14.60% | 3 | Jul 16, 2025 | |
| CNC Centene | Downgrades: Underperform | $52 → $30 | $29.64 | +1.21% | 13 | Jul 16, 2025 | |
| UHS Universal Health Services | Downgrades: Underperform | $215 → $185 | $181.59 | +1.88% | 15 | Jul 16, 2025 | |
| HCA HCA Healthcare | Downgrades: Neutral | $394 → $410 | $406.73 | +0.80% | 11 | Jul 16, 2025 | |
| HUM Humana | Maintains: Neutral | $320 → $260 | $312.21 | -16.72% | 15 | Jun 17, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $165 → $180 | $184.87 | -2.63% | 5 | May 14, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $23.23 | +91.56% | 6 | Feb 28, 2025 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $20.61 | +132.90% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $1.28 | +135.29% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $139 → $145 | $136.00 | +6.62% | 12 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $646 → $530 | $324.32 | +63.42% | 3 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $183.84 | +138.79% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $9.30 | -30.11% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $16.49 | -56.03% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $302.53 | +15.69% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $22.44 | +100.53% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $122.99 | -39.83% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.79 | +97.49% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.91 | +171.11% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $2.63 | +280.23% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $13.30 | -43.61% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $28.48 | -36.79% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $16.67 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $36.48 | -47.92% | 2 | Feb 9, 2018 |
UnitedHealth Group
Aug 18, 2025
Maintains: Neutral
Price Target: $290 → $325
Current: $310.29
Upside: +4.74%
Ardent Health
Jul 16, 2025
Downgrades: Underperform
Price Target: $16 → $15
Current: $12.74
Upside: +14.60%
Centene
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $29.64
Upside: +1.21%
Universal Health Services
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $181.59
Upside: +1.88%
HCA Healthcare
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $406.73
Upside: +0.80%
Humana
Jun 17, 2025
Maintains: Neutral
Price Target: $320 → $260
Current: $312.21
Upside: -16.72%
Tenet Healthcare
May 14, 2025
Maintains: Buy
Price Target: $165 → $180
Current: $184.87
Upside: -2.63%
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $23.23
Upside: +91.56%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $20.61
Upside: +132.90%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $1.28
Upside: +135.29%
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $136.00
Upside: +6.62%
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $324.32
Upside: +63.42%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $183.84
Upside: +138.79%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $9.30
Upside: -30.11%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $16.49
Upside: -56.03%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $302.53
Upside: +15.69%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $22.44
Upside: +100.53%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $122.99
Upside: -39.83%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.79
Upside: +97.49%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $12.91
Upside: +171.11%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $2.63
Upside: +280.23%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $13.30
Upside: -43.61%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $28.48
Upside: -36.79%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $16.67
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $36.48
Upside: -47.92%